Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b7a5c546db0678dbd6f9594fc43f2d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbd1d44888f5b41142d83de455096387 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F19-005 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2020-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c971ca9ba81cfd8be19b6633d59d5357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7885764240ccb8ddeb4a9460e8ba4dbe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd5a0814dc7d2b04039f27bbb74390b5 |
publicationDate |
2021-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021284674-A1 |
titleOfInvention |
Phosphinogold(i) complexes and methods of treating cancer |
abstract |
Mixed ligand phosphinogold(I) complexes as anticancer agents. The gold(I) ion of the complexes is coordinated to a phosphine and a dithiocarbamate or halogen ligand. Also described are a pharmaceutical composition incorporating the phosphinogold(I) complex, a method of synthesizing the phosphinogold(I) complex, and a method of treating cancer. The phosphinogold(I) complexes exhibit potent cytotoxicity against lung, cervical, and liver cancer cells. |
priorityDate |
2020-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |